Search
Search
Close this search box.

A look at monthly cannabis sales in Canada

The CCSI was assessed at C$5.13 per gram this week, down 1.3% from last week’s C$5.20 per gram. This week’s price equates to US$1,833 per pound at the current exchange rate.

cannabis news about the monthly cannabis sales in canada

Each week, Business of Cannabis delivers a series of insights from our partners at Cannabis Benchmarks®.

This week, Cannabis Benchmarks examines updated household expenditure data issued quarterly by Statistics Canada. As seen in the chart above, in Q4 2021 the estimated household expenditure for legal recreational cannabis continued to grow, while estimated expenditures in the illicit market continued to contract.

More Canadians are choosing to purchase cannabis through regulated legal channels, as awareness and accessibility continue to evolve. Also fueling that trend is the drop in prices, as new supplies from legal indoor and outdoor cultivation operations became available, making products from licensed businesses more price-competitive with those of illegal sellers.

In Q4 2021, recreational cannabis expenditures grew 33% to C$1,224M and illicit cannabis expenditures dropped by 13% to C$660M compared to the same time frame in 2020. Cannabis Benchmarks also note that expenditures for medical-use cannabis dropped 13% to C$108M. Medical cannabis now makes up only 5.4% of the total Canadian cannabis market. Total expenditures on cannabis were C$1.993B for the quarter, or C$21.7M per day.

Source: Canada Cannabis Spot IndexCannabis Benchmarks

See previous weekly updates from Cannabis Benchmarks:



🔒 Risk Management Report • Produced in partnership with RELM
Prohibition Partners RELM
📊 New Report Available Now

Relm Risk Briefing: Cannabis 2026

The global cannabis sector has moved from experiment to enterprise. This comprehensive risk briefing examines how regulation, insurance, and operational practices intersect across the international supply chain, drawing on insights from RELM—the only insurer entirely dedicated to the cannabis industry.

What's covered

  • 🌱 Cultivation risk management — biological contamination, environmental instability, and security protocols
  • ⚗️ Manufacturing & extraction — GMP standards, in-house testing, and quality control measures
  • 🔬 Testing & compliance — rigorous protocols ensuring product safety and regulatory adherence
  • 📦 Distribution & logistics — GDP-aligned transport, route monitoring, and cargo insurance
Key focus areas
Cultivation Manufacturing Testing & QC Packaging Distribution Retail & Pharmacy
100% free • Comprehensive risk analysis

Key insights

Industry Maturity Cannabis has evolved from patchwork markets to international enterprise, with risk management now the measure of long-term stability.
Cultivation Challenges Operators addressing biological contamination through controlled-environment agriculture, tissue culture, and IPM protocols.
Quality Control GMP adherence, in-house testing, and selective supplier relationships emerging as critical control points.
Supply Chain Security GDP-aligned transport, route monitoring, and comprehensive insurance remain essential safeguards.
Market Access Initiatives stabilizing domestic supply and expanding pharmacy training improving patient and consumer access.
Produced by Prohibition Partners in collaboration with RELM—the only insurer dedicated to emerging industries like cannabis.
Partnership
Produced by Prohibition Partners in collaboration with RELM

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

CATEGORIES

EDITION

BUSINESS OF CANNABIS

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?